C94.4
Acute panmyelosis with myelofibrosis
Clinical Classification Guidelines
Inclusion Terms
- Acute myelofibrosis
Excludes Type 1
- myelofibrosis NOS (D75.81)
- secondary myelofibrosis NOS (D75.81)
Medical Intelligence & Overview
Acute panmyelosis with myelofibrosis is a rare and aggressive form of blood cancer that affects the bone marrow. It is characterized by the simultaneous disruption of blood cell production and the fibrous (scarring) changes in the bone marrow. This condition leads to a deficiency in healthy blood cells, resulting in various health complications. Due to its rapid progression and complex nature, timely understanding and diagnosis are crucial for managing the disease effectively.
Causes & Symptoms
Clinical Causes: The exact cause of acute panmyelosis with myelofibrosis remains unknown. Certain genetic mutations may play a role in the development of the disease. Exposure to radiation or certain chemotherapy treatments could potentially increase the risk. No clear environmental or lifestyle factors have been definitively linked to the condition. Like other hematologic malignancies, it may involve abnormal DNA changes in the stem cells of the bone marrow.
Key Symptoms: Significant fatigue and weakness Easy bruising or bleeding due to low platelet counts Frequent or severe infections because of reduced white blood cells Unexplained weight loss Fever and night sweats Enlarged spleen or liver causing fullness or discomfort in the abdomen Anemia-related symptoms such as pale skin and shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute panmyelosis with myelofibrosis involves multiple steps:
Treatment Protocols: Treatment approaches focus on managing symptoms, controlling disease progression, and improving quality of life:
Clinical Advice & FAQs
Billing Guidance
Is C94.4 a billable ICD-10 code?
Yes, C94.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.4?
Clinical documentation must specify the nature of Acute panmyelosis with myelofibrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
